Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Genome Ed., 07 November 2025

Sec. Genome Editing in Human Health and Disease

Volume 7 - 2025 | https://doi.org/10.3389/fgeed.2025.1719330

Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease

This article is a correction to:

  1. Rewriting the script: gene therapy and genome editing for von Willebrand Disease

    1. Read original article
Alastair Barraclough&#x;Alastair Barraclough1†Isabel Br&#x;Isabel Bär2†Tirsa van DuijlTirsa van Duijl3Karin FijnvandraatKarin Fijnvandraat1Jeroen C. J. EikenboomJeroen C. J. Eikenboom4Frank W. G. LeebeekFrank W. G. Leebeek2Ruben BieringsRuben Bierings2Jan Voorberg Jan Voorberg3*Despoina Trasanidou&#x;Despoina Trasanidou3†
  • 1Department of Pediatric Hematology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
  • 2Department of Hematology, Erasmus University Medical Centre, Rotterdam, Netherlands
  • 3Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam, Netherlands
  • 4Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden University Medical Centre, Leiden, Netherlands

A Correction on
Rewriting the script: gene therapy and genome editing for von Willebrand Disease

by Barraclough A, Bär I, van Duijl T, Fijnvandraat K, Eikenboom JCJ, Leebeek FWG, Bierings R, Voorberg J and Trasanidou D (2025). Front. Genome Ed. 7:1620438. doi: 10.3389/fgeed.2025.1620438

There was a mistake in the caption of Figure 1 as published. The legend of Figure 1 included text from an older version of the figure, which should have been removed. The incorrect caption read: Overview of von Willebrand Disease sub-types, von Willbrand Factor (VWF) domains, and variant distributions. (A) Summary of von Willebrand Disease sub-types (A) Von Willebrand Factor domains and binding sites. (B) Distribution and frequency of von Willebrand Factor variants curated in the Leiden Open Variation Database (LOVD) (Accessed and data retrieved on 8-1-2025). Created in BioRender.

The corrected caption of Figure 1 appears below.

Overview of von Willbrand Factor (VWF) domains, and variant distributions. (A) Von Willebrand Factor domains and binding sites. (B) Distribution and frequency of von Willebrand Factor variants curated in the Leiden Open Variation Database (LOVD) (Accessed and data retrieved on 8-1-2025). Created in BioRender.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: gene therapy, VWD, endothelial cells, delivery, CRISPR-Cas, in vivo delivery

Citation: Barraclough A, Bär I, van Duijl T, Fijnvandraat K, Eikenboom JCJ, Leebeek FWG, Bierings R, Voorberg J and Trasanidou D (2025) Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease. Front. Genome Ed. 7:1719330. doi: 10.3389/fgeed.2025.1719330

Received: 06 October 2025; Accepted: 17 October 2025;
Published: 07 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Barraclough, Bär, van Duijl, Fijnvandraat, Eikenboom, Leebeek, Bierings, Voorberg and Trasanidou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jan Voorberg, ai52b29yYmVyZ0BzYW5xdWluLm5s

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.